SUBLOCADE 100 mg/1

SUBLOCADE 100 mg/1 is a buprenorphine solution designed for subcutaneous use. This medication is used to treat opioid dependence and is administered as a monthly injection. It is manufactured by Indivior Inc. in the USA.

SUBLOCADE 100 mg/1 is primarily used for the treatment of opioid dependence. It is a long-acting formulation of buprenorphine, which helps manage withdrawal symptoms and cravings associated with opioid addiction. This medication is administered subcutaneously, typically once a month, to provide sustained relief and support recovery efforts.

Common effects of SUBLOCADE 100 mg/1 may include injection site reactions such as pain, swelling, or redness. Some individuals might experience constipation, nausea, or headache. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

SUBLOCADE 100 mg/1 should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. This medication should not be used by individuals who are allergic to buprenorphine or any of its components.

SUBLOCADE 100 mg/1 may interact with other medications, including central nervous system depressants like alcohol, benzodiazepines, and other opioids. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.